Organometallics
Article
C36H54Cl3N5OTi 725.29, found 529.51. The complex was not stable
under the mass spectrum conditions; the mass found corresponds to
the iminium ligand (calcd for C34H49N4O 529.78). Anal. Calcd for
C36H54Cl3N5OTi·0.5CH2Cl2: C, 56.97; H, 7.20; N, 9.10. Found: C,
56.89; H, 7.38; N, 9.09.
Synthesis and Characterization of Titanium Complex 6. A
solution of complex 5 in methylene chloride was heated overnight at
50 °C to quantitatively yield complex 6 as a brown solid. Crystals of 6
can be obtained by cooling at −20 °C a solution of 6 in a CH2Cl2/
1
pentane mixture. H NMR (400 MHz, CD2Cl2, 25 °C): δ 10.61 (s,
1H, NCHN), 8.02 (m, 1H, CH), 7.79 (m, 1H, CH), 7.62 (m, 1H,
CH), 7.20 (m, 2H, CH), 7.06 (m, 2H, CH), 6.22 (s, 1H, CH), 5.48
(br s, 2H, NCH2), 4.98−4.63 (br s, 2H, NCH2), 4.10 (br s, 1H,
HNMe2), 2.91 (br s, 3H, NMe2), 2.63 (br s, 3H, NMe2), 2.41 (br s,
3H, CH3), 1.63 (br s, 6H, CH3), 1.16 (s, 9H, tBu), 0.55 (s, 9H, tBu).
1H NMR (500 MHz, CD2Cl2, −30 °C): δ 10.56 (s, 1H, NCHN), 8.01
(d, J = 8.3 Hz, 1H, CH), 7.82 (pt, J = 7.8 Hz, 1H, CH), 7.66 (m, 1H,
CH), 7.21 (m, 1H, CH), 7.04 (m, 2H, CH), 7.00 (s, 1H, CH), 6.14 (s,
1H, CH), 5.70 (m, 1H, NCH2), 5.51 (m, 1H, NCH2), 4.96 (m, 1H,
NCH2), 4.16 (m, 1H, HNMe2), 3.84 (m, 1H, NCH2), 3.04 (d, J = 6.2
Hz, 3H, HNMe2), 3.00 (d, J = 6.2 Hz, 3H, HNMe2), 2.34 (s, 3H,
CH3), 1.82 (s, 3H, CH3), 1.32 (s, 3H, CH3), 1.12 (s, 9H, tBu), 0.46 (s,
9H, tBu). 13C NMR (125 MHz, CD2Cl2, −30 °C): δ 150.9 (C), 150.2
(C), 145.0 (C), 143.8 (NCHN), 141.6 (C), 135.6 (C), 134.9 (C),
131.7 (C), 131.1 (C), 130.0 (CH), 129.8 (CH), 128.2 (CH), 128.1
(CH), 128.0 (CH), 127.5 (C), 117.7 (CH), 113.9 (CH), 112.8 (CH),
52.3 (NCH2), 50.8 (NCH2), 43.6 (NMe2), 43.1 (NMe2), 33.8 (CtBu),
33.6 (CtBu), 30.5 (CHtBu), 29.1 (CHtBu), 21.0 (CH3), 17.5 (CH3), 16.5
(CH3). MS (FAB+): m/z calcd for C34H47Cl3N4OTi 682.22, found
484.33. The complex was not stable under the mass spectrum
conditions, the mass found corresponds to the benzimidazolium ligand
(calcd for C34H42N3O 484.33). Anal. Calcd for C34H47Cl3N4OTi: C,
59.88; H, 6.95; N, 8.22. Found: C, 59.20; H, 7.23; N, 8.22.
Figure 3. Molecular structure of complex 7. Selected bond lengths (Å)
and angles (deg): Zr(1)−N(1) = 2.397(2), Zr(1)−N(2) = 2.439(2),
Zr(1)−N(3) = 2.117(2), Zr(1)−O(1) = 2.0518(18); N(3)−Zr(1)−
N(2) = 70.22(8), O(1)−Zr(1)−N(1) = 69.84(7), N(1)−Zr(1)−N(2)
= 53.81(7), C(47)−Zr(1)−C(40) = 86.50(10), Zr(1)−C(47)−C(48)
= 115.00(18), Zr(1)−C(40)−C(41) = 136.9(2).
Synthesis and Characterization of (OCO)ZrBn2 (4). To a
suspension of N,N′-bis(2-hydroxy-3,5-di-tert-butylphenyl)-4,5-dihy-
droimidazolinium chloride salt (50 mg, 0.097 mmol) in toluene (5
mL) was added a solution of ZrBn4 (44 mg, 0.097 mmol) in toluene
(5 mL). After 2 h, benzyl Grignard (96 μL, 0.096 mmol) was added
and the mixture was stirred for 1 h. The reaction mixture was then
filtered through Celite and evaporated to dryness. After several washes
with pentane, complex 4 was obtained as a yellow powder (32 mg,
35%). 1H NMR (500 MHz, C6D6): δ 7.50 (d, J = 2.3 Hz, 2H,
CHPhOH), 6.98 (d, J = 7.5 Hz, 4H, CHBn), 6.86 (t, J = 7.5 Hz, 4H,
CHBn), 6.74 (d, J = 2.3 Hz, 2H, CHPhOH), 6.61 (t, J = 7.5 Hz, 2H,
CHBn), 3.24 (s, 4H, NCH2), 2.42 (s, 4H, CH2Ph), 1.82 (s, 18H, tBu),
1.46 (s. 18H, tBu). 13C NMR (125 MHz, C6D6): δ 205.9 (Ccarbene),
148.4 (C), 140.4 (C), 139.4 (C), 137.6 (C), 132.1 (C), 129.4 (CH),
129.3 (CH), 122.4 (CH), 119.2 (CH), 112.3 (CH), 55.6 (CH2Ph),
47.7 (NCH2), 36.2 (CtBu), 34.9 (CtBu), 32.2 (CH3,tBu), 30.6 (CH3,tBu).
Anal. Calcd for C45H59N2O2Zr: C, 71.95; H, 7.92; N, 3.73. Found: C,
72.20; H, 7.80; N, 3.44.
Synthesis and Characterization of (NNNO)ZrBn2 (7). To a
suspension of imidazolium 1 (50 mg, 0.096 mmol) in toluene (5 mL)
was added a solution of ZrBn4 (44 mg, 0.096 mmol) in toluene (5
mL). After 2 h, benzyl Grignard (96 μL, 0.096 mmol) was added and
the mixture stirred for 1 h. The reaction mixture was then evaporated
to dryness, and the residue was solubilized in pentane. After filtration
through Celite, the solution was concentrated and stored in the
refrigerator; a yellow solid precipitated, yielding complex 7 (47 mg,
1
52%). H NMR (500 MHz, C6D6): δ 7.45 (d, J = 2.3 Hz, 1H, CH),
7.11 (m, 2H, CH), 7.02 (m, 4H, CH), 6.93−6.81 (m, 9H, CH), 6.68−
6.61 (m, 4H, CH), 6.07 (d, J = 8.2 Hz, 1H, CH), 5.91 (dd, J = 7.7 Hz,
J = 1.8 Hz, 2H, CH), 4.48 (t, J = 3.4 Hz, 1H, NCHBnN), 3.01 (m, 1H,
NCH2), 2.93 (m, 1H, NCH2), 2.87 (m, 1H, NCH2), 2.78 (m, 1H,
NCH2), 2.65 (d, J = 11.9 Hz, 1H, CH2Ph), 2.55 (d, J = 11.2 Hz, 1H,
CH2Ph), 2.43 (dd, J = 11.5, 9.2 Hz, 2H, CH2Ph), 2.37 (dd, J = 14.7,
3.8 Hz, 1H, CH2Ph), 2.26 (dd, J = 14.7, 2.9 Hz, 1H, CH2Ph), 2.21 (s,
3H, CH3,Mes), 2.16 (s, 3H, CH3,Mes), 1.73 (s, 3H, CH3,Mes), 1.55 (s, 9H,
tBu), 1.37 (s, 9H, tBu). 13C NMR (125 MHz, C6D6): δ 159.6 (C),
153.9 (C), 151.0 (C), 148.8 (C), 142.1 (C), 140.3 (C), 138.8 (C),
136.9 (C), 136.9 (C), 135.3 (C), 134.5 (C), 131.3 (CH), 130.1 (CH),
129.2 (CH), 129.1 (C), 128.8 (CH), 128.6 (CH), 128.6 (CH), 128.4
(CH), 128.1 (CH), 126.7 (CH), 126.8 (CH), 126.7 (CH), 123.3
(CH), 122.1 (CH), 120.8 (C), 120.3 (CH), 116.1 (CH), 114.7 (CH),
113.42 (CH), 77.6 (CH2Ph), 70.3 (CH2Ph), 69.2 (NCHBnN), 43.6
(NCH2), 42.6 (NCH2), 35.4 (CtBu), 34.6 (CtBu), 31.9 (CH3,tBu), 30.5
(CH3,tBu), 29.6 (CH2PhNCHN), 21.0 (CH3,Mes), 18.9 (CH3,Mes), 18.8
(CH3,Mes). Anal. Calcd for C53H61N3OZr: C, 75.13; H, 7.26; N, 4.96.
Found: C, 74.80; H, 6.90; N, 5.14.
Synthesis and Characterization of Titanium Complex 5. A
solution of TiCl2(NMe2)2 (16 mg, 0.077 mmol) in methylene chloride
(2 mL) was added to a solution of imidazolium salt 1 (40 mg, 0.077
mmol) in methylene chloride (5 mL). After it was stirred for 1 h, the
solution was evaporated to dryness to quantitatively yield complex 5 as
a brown solid. Crystals of 5 can be obtained by cooling at −20 °C a
1
solution of 5 in a CH2Cl2/pentane mixture. H NMR (600 MHz,
CD2Cl2): δ 9.02 (s, 1H, NCHN), 7.30 (dd, J = 7.7 Hz, J = 1.4 Hz, 1H,
CH), 7.14 (td, J = 8.3 Hz, J = 1.4 Hz, 1H, CH), 6.97 (m, 2H, CH),
6.73 (td, J = 7.7 Hz, J = 1.2 Hz, 1H, CH), 6.49 (d, J = 1.6 Hz, 1H,
CH), 6.27 (br s, 1H, NH), 6.13 (dd, J = 8.3 Hz, J = 1.2 Hz, 1H, CH),
5.57 (br s, 1H, CH), 4.39 (m, 2H, NCH2), 3.92 (br s, 1H, NCH2),
3.65 (br s, 1H, NCH2), 3.36 (s, 3H, NMe2), 2.83 (br s, 6H, HNMe2),
2.68 (s, 3H, NMe2), 2.47 (br s, 1H, HNMe2), 2.29 (s, 3H, CH3Mes),
2.19 (br s, 3H, CH3Mes), 1.97 (br s, 3H, CH3Mes), 1.16 (s, 9H, tBu),
1.14 (s, 9H, tBu). 13C NMR (151 MHz, CD2Cl2): δ 157.9 (NCHN),
150.7 (C), 145.6 (C), 142.5 (C), 136.6 (C), 136.7 (C), 133.3 (C),
131.4 (C), 131.2 (CH), 129.3 (CH), 127.8 (CH), 123.4 (C), 117.9
(CH), 117.5 (C), 116.8 (CH), 112.6 (CH), 102.2 (CH), 50.7
(NCH2), 49.2 (NCH2), 46.7 (NMe2), 42.2 (HNMe2), 37.9 (NMe2),
35.2 (CtBu), 34.4 (CtBu), 31.2 (CHtBu), 29.2 (CHtBu), 20.7 (CH3,Mes),
18.4 (CH3,Mes), 18.1 (CH3,Mes). MS (FAB+): m/z calcd for
ASSOCIATED CONTENT
■
S
* Supporting Information
Tables, figures, and CIF files giving crystallographic data. This
material is available free of charge via the Internet at http://
D
dx.doi.org/10.1021/om4001567 | Organometallics XXXX, XXX, XXX−XXX